AMNEAL PHARMACEUTICALS INC's ticker is AMRX and the CUSIP is 03168L105. A total of 161 filers reported holding AMNEAL PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 1.18 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $301,367 | +36.1% | 71,414 | 0.0% | 0.22% | +38.9% |
| Q2 2023 | $221,383 | +123.0% | 71,414 | 0.0% | 0.16% | +112.2% |
| Q1 2023 | $99,265 | -30.2% | 71,414 | 0.0% | 0.07% | -31.5% |
| Q4 2022 | $142,114 | -1.3% | 71,414 | 0.0% | 0.11% | -5.3% |
| Q3 2022 | $144,000 | -36.6% | 71,414 | 0.0% | 0.11% | -34.5% |
| Q2 2022 | $227,000 | -23.8% | 71,414 | 0.0% | 0.17% | -17.9% |
| Q1 2022 | $298,000 | -12.9% | 71,414 | 0.0% | 0.21% | -11.3% |
| Q4 2021 | $342,000 | -10.2% | 71,414 | 0.0% | 0.24% | -16.1% |
| Q3 2021 | $381,000 | +4.1% | 71,414 | 0.0% | 0.28% | +3.6% |
| Q2 2021 | $366,000 | -23.9% | 71,414 | 0.0% | 0.28% | -29.1% |
| Q1 2021 | $481,000 | +47.5% | 71,414 | 0.0% | 0.39% | +31.1% |
| Q4 2020 | $326,000 | – | 71,414 | – | 0.30% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fosun International Ltd | 19,552,001 | $433,859,000 | 20.80% |
| BRIDGER MANAGEMENT, LLC | 2,642,621 | $58,640,000 | 3.39% |
| TPG Group Holdings (SBS) Advisors, Inc. | 3,884,600 | $86,199,000 | 1.10% |
| HUSSMAN STRATEGIC ADVISORS, INC. | 125,000 | $2,774,000 | 0.80% |
| HealthCor Management, L.P. | 1,036,110 | $22,991,000 | 0.76% |
| GW&K Investment Management, LLC | 2,049,765 | $45,484,000 | 0.73% |
| Bridge City Capital, LLC | 50,434 | $1,119,000 | 0.70% |
| TCW GROUP INC | 2,521,064 | $55,942,000 | 0.46% |
| FRONTIER CAPITAL MANAGEMENT CO LLC | 2,876,367 | $63,827,000 | 0.41% |
| Quadrant Capital Management, LLC | 25,002 | $555,000 | 0.35% |